Biological Computing Global Market Report 2026

Biological computing is a computing approach that utilizes biological components such as deoxyribonucleic acid (DNA), proteins, and living cells to carry out data processing, storage, and problem-solving tasks. It performs computation by taking advantage of biochemical reactions and molecular interactions rather than relying on conventional silicon-based electronic systems, offering high levels of parallelism and energy-efficient processing capabilities.

The essential component categories of biological computing include hardware and devices, consumables, software, and services. Hardware refers to physical components such as bio-compatible sensors, processing units, and lab-on-chip devices that facilitate the capture, processing, and execution of biological computations. The deployment modes include biocomputing-as-a-service (BaaS) and on-premise wet kits, with key applications covering data storage and archiving, drug discovery and bioinformatics, biosensing and diagnostics, and complex optimization. The primary end users include pharmaceutical and biotechnology companies, academic and research institutions, information technology and data storage providers, healthcare and diagnostics organizations, as well as environmental and industrial sectors.

Tariffs are affecting the biological computing market by increasing the cost of imported laboratory equipment, microfluidic chips, deoxyribonucleic acid sequencing systems, and essential consumables such as reagents and enzymes, thereby disrupting research supply chains and raising operational costs. This effect is most significant in hardware and consumables segments, particularly in regions like North America, Europe, and Asia-Pacific that depend on global biotechnology trade and specialized imports. As a result, applications such as drug discovery, bioinformatics, and biosensing in pharmaceuticals, biotechnology companies, and research institutions are facing budget limitations and slower experimentation processes. However, tariffs are also encouraging domestic production of biotech equipment and consumables, strengthening local research ecosystems, and promoting greater adoption of cloud-based biocomputing services and outsourcing models to enhance cost efficiency and accessibility.

The biological computing market research report is one of a series of new reports from The Business Research Company that provides biological computing market statistics, including biological computing industry global market size, regional shares, competitors with a biological computing market share, detailed biological computing market segments, market trends and opportunities, and any further data you may need to thrive in the biological computing industry. This biological computing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biological computing market size has grown exponentially in recent years. It will grow from $2.21 billion in 2025 to $2.9 billion in 2026 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to advancements in dna sequencing technologies, growth in genomics research funding, development of synthetic biology techniques, increasing demand for high performance computing alternatives, expansion of bioinformatics research ecosystems.

The biological computing market size is expected to see exponential growth in the next few years. It will grow to $8.64 billion by 2030 at a compound annual growth rate (CAGR) of 31.4%. The growth in the forecast period can be attributed to rising demand for ultra energy efficient computing systems, increasing adoption of personalized medicine applications, breakthroughs in dna data storage technologies, expansion of hybrid biological-digital computing models, growing investments in biotech computing startups. Major trends in the forecast period include dna-based computational architecture scaling, synthetic biology driven computing systems, bio-integrated hybrid computing platforms, molecular data storage and retrieval systems, laboratory automation for biocomputing workflows.

The increasing adoption of synthetic biology technologies is anticipated to drive the growth of the biological computing market in the coming years. Synthetic biology technologies refer to a range of engineering and biotechnology tools and methods used to design or construct biological systems for creating or modifying genetic code. The rise in synthetic biology technologies is driven by advancements in genetic engineering and biotechnology aimed at designing and modifying living organisms for useful medical applications. Biological computing supports synthetic biology technologies by enabling living cells to be engineered to process information and perform logical operations, allowing precise control of biological functions. For example, GenBank, a US-based public genetic sequence repository maintained by the National Centre for Biotechnology Information, reported that the database contained approximately 25 trillion base pairs and about 3.7 billion sequences in 2024, compared with around 34 trillion base pairs and 4.7 billion sequences in 2025, reflecting substantial year-over-year growth in global genomic data accumulation and sequencing output. Therefore, the increasing adoption of synthetic biology technologies is driving the growth of the biological computing market.

Key companies operating in the biological computing market are increasingly focusing on developing innovative solutions, such as biocomputing online research platforms, to enable remote experimentation on living neural systems, accelerate brain-inspired computing research, and enhance the development of energy-efficient, adaptive computing technologies. Biocomputing online research platforms are cloud-based systems that allow researchers to remotely access and experiment on biological components, such as living neurons, to study and develop brain-inspired computing technologies. For example, in May 2024, FinalSpark SA, a Switzerland-based biotechnology research company, launched the Neuroplatform, the first remote research platform for biocomputing using human brain organoids by enabling scientists to access living neuron-based systems over the cloud, apply real-time electrical stimulation and record electrophysiological responses through multi-electrode arrays for continuous experimentation in organoid-based neural computation. Additionally, it also provides researchers with a cloud-based interface for remote experiment control, real-time electrophysiological monitoring, and data acquisition from living neuronal networks, along with long-duration biological system maintenance, enabling continuous experimentation on human brain organoids under controlled laboratory conditions.

In November 2023, VERSES Technologies Inc., a Canada-based artificial intelligence firm focused on cognitive computing and adaptive intelligence systems, formed a beta partnership with Cortical Labs Pty Ltd to study and assess living neuronal networks. Through this collaboration, VERSES Technologies seeks to investigate and create innovative methods for biological computing by combining its artificial intelligence frameworks with living neural networks cultivated under laboratory conditions, enabling experimentation in hybrid intelligence systems that merge silicon-based computation with biological neurons. Cortical Labs Pty Ltd is an Australia-based neurotechnology company that specializes in biological computing systems using cultured neurons and hybrid neural-silicon platforms.

Major companies operating in the biological computing market are Thermo Fisher Scientific Inc., Illumina Inc., Ginkgo Bioworks Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies plc, Synthego Corporation, Touchlight Genetics Ltd., Arzeda Corporation, Asimov Inc., LabGenius Ltd., ProteinQure Inc., Molecular Assemblies Inc., Catalog Technologies Inc., Iridia Inc., Helixworks Technologies Ltd., FinalSpark AG, Cortical Labs Pty Ltd., Biomemory SA, DNAli Data Technologies Inc., Atlas Data Storage Inc.

North America was the largest region in the biological computing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological computing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biological computing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biological computing market consists of revenues earned by entities by providing services such as bio-computational system design, synthetic biology-based computing solutions, biochip development, molecular data storage solutions, and system integration for hybrid biological-digital platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The biological computing market also includes sales of DNA synthesis tools, biochips, laboratory automation systems, microfluidic devices, sequencing platforms, and molecular computing kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biological Computing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biological computing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biological computing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biological computing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Hardware And Devices; Consumables; Software; Services
• 2) By Technology: Deoxyribonucleic Acid (DNA)-Based Computing; Cell-Based Computing; Protein-Based Computing; Molecular Or Biochemical Computing
• 3) By Deployment: Biocomputing-As-A-Service (BaaS); On-Premise Wet Kits
• 4) By Application: Data Storage And Archiving; Drug Discovery And Bioinformatics; Biosensing And Diagnostics; Complex Optimization
• 5) By End-User: Pharmaceuticals And Biotechnology; Academic And Research Institutes; Information Technology And Data Storage Providers; Healthcare And Diagnostics; Environmental And Industrial Applications
• Subsegments:
• 1) By Hardware And Devices: Biological Computing Hardware Platforms; Biosensors; Microfluidic Chips; Deoxyribonucleic Acid Sequencers; Laboratory Automation Systems; Biological Processing Units
• 2) By Consumables: Reagents; Enzymes; Nucleotides; Biological Samples; Assay Kits; Cell Culture Media
• 3) By Software: Bioinformatics Software; Computational Biology Platforms; Molecular Modeling Software; Biological Data Analysis Software; Workflow Management Software; Simulation And Modeling Software
• 4) By Services: Contract Research Services; Deoxyribonucleic Acid Sequencing Services; Biological Data Analysis Services; Cloud Based Computing Services; Biotechnology Consulting Services; Laboratory Outsourcing Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Ginkgo Bioworks Inc.; Twist Bioscience Corporation; Oxford Nanopore Technologies plc; Synthego Corporation; Touchlight Genetics Ltd.; Arzeda Corporation; Asimov Inc.; LabGenius Ltd.; ProteinQure Inc.; Molecular Assemblies Inc.; Catalog Technologies Inc.; Iridia Inc.; Helixworks Technologies Ltd.; FinalSpark AG; Cortical Labs Pty Ltd.; Biomemory SA; DNAli Data Technologies Inc.; Atlas Data Storage Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.